Pengana Capital Group Ltd. (AU:PCG) has released an update.
Pengana Capital Group Ltd has emerged as a substantial holder in Oncosil Medical Ltd, with a voting power of 10.19% through 385,714,286 fully paid ordinary shares. The significant acquisition, confirmed by Chief Investment Officer Nick Griffiths, indicates Pengana’s vested interest in the medical company’s future. Details surrounding the acquisition’s consideration, and the association of involved parties, were outlined without specific financial figures.
For further insights into AU:PCG stock, check out TipRanks’ Stock Analysis page.
